Nanofiber-expanded human umbilical cord blood–derived CD34(+) cell therapy accelerates cutaneous wound closure in NOD/SCID mice

Nanofiber-expanded human umbilical cord blood–derived CD34(+) cell therapy has been shown to have potential applications for peripheral and myocardial ischaemic diseases. However, the efficacies of expanded CD34(+) cell therapy for treating cutaneous wounds and its mechanisms of action have yet to b...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanji, Suman, Das, Manjusri, Aggarwal, Reeva, Lu, Jingwei, Joseph, Matthew, Pompili, Vincent J, Das, Hiranmoy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981939/
https://www.ncbi.nlm.nih.gov/pubmed/24455991
http://dx.doi.org/10.1111/jcmm.12217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981939/
https://www.ncbi.nlm.nih.gov/pubmed/24455991
http://dx.doi.org/10.1111/jcmm.12217

Ejemplares similares